Drugs / mixed oil lipid emulsion
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT06915441 Comparator | Apr 2026 → Jul 2028 expected | bronchopulmonary dysplasia, neurodevelopmental disorder | The University of Texas Health Science Center, Houston | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | mixed oil lipid emulsion | “mixed oil lipid emulsion (MOLE)” NCT06915441 ↗ |
| Known as | MOLE | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06915441 ↗ |